InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Malady Kyle, Vice-Président Exécutif. Insider active across 2 companies, notably DEXCOM INC. Aggregated, 6 filings have been published. The latest transaction was disclosed on 20 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€1979 shares@ €0.00090.0000% mcap38.4% of flow
Common Stock
SEC:0001093557-22-000120:0·
9,419 shares
Common Stock
SEC:0001062993-22-007263:0·
11,450 shares
Common Stock
SEC:0001062993-22-006785:0·
13,238 shares
Common Stock
SEC:0001062993-22-006559:0·
€1910 shares@ €0.00080.0000% mcap100.0% of flow
Common Stock
SEC:0001093557-21-000146·
€1910 shares@ €0.00080.0000% mcap30.8% of flow
Common Stock
SEC:0001093557-21-000146:0·
6 of 6 declarations
About Malady Kyle
Kyle Malady is the Executive Vice President and President of Global Networks and Technology at DEXCOM INC and VERIZON COMMUNICATIONS INC. In these roles, he oversees operations and contributes to the company's strategy. Kyle Malady is responsible for managing teams and optimizing processes to ensure efficiency and profitability. His experience in the technology sector is an asset to the companies.
